Latest Strategic Outlook News

M3 Mining advances exploration at its Victoria Bore and Edjudina projects with promising high-grade gold and copper findings, supported by a solid cash position of $1.9 million.

Xanadu Mines has delivered a landmark Pre-Feasibility Study and Maiden Ore Reserve for its Kharmagtai Copper-Gold Project, confirming its status as a world-class asset. The company also secured $7.5 million in funding and transitioned project operatorship to Zijin Mining, setting the stage for a Bankable Feasibility Study.

Koba Resources has revealed significant high-grade uranium mineralisation at its Yarramba Project in South Australia, with promising drilling results at the Berber and Chivas Prospects. The company plans to accelerate exploration in 2025, aiming to expand its resource base.

Electro Optic Systems (EOS) has completed the divestment of its EM Solutions subsidiary for $158.6 million, wiping out all borrowings and positioning itself with a strong cash balance of approximately $128 million. The company is actively pursuing significant defence contracts and expanding its manufacturing footprint.

Freehill Mining has reported a record-breaking December quarter with gross sales doubling to $954,000 and a significant improvement in operating cash flow, positioning the company for sustained growth in 2025.

Group 6 Metals Limited reveals a challenging quarter marked by safety incidents and production setbacks at its Dolphin Tungsten Mine, while initiating a major recapitalisation plan to stabilise finances and leadership.

Mount Ridley Mines has reported promising rock chip sampling results from its Weld Range West Iron Project, with assays reaching up to 62.03% iron content. The company is preparing for further exploration to better understand the potential of these high-grade zones.

Noumi Limited’s Q2 FY25 results reveal a resilient plant-based milks segment driving growth, even as traditional dairy and nutritionals face margin pressures amid a challenging market.

Botala Energy has secured critical environmental approvals for its Serowe CBM Project and successfully raised A$1.87 million, positioning the company for commercial gas production in Southern Africa.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for Autosomal Dominant Optic Atrophy, marking a pivotal step in developing a treatment for this currently untreatable blinding disease.

Propell Holdings has reported its first half-year cash profit since its 2021 ASX listing, driven by loan book growth and new product launches, despite a Q2 operating cash outflow.

LiveHire’s 2Q25 report reveals a sharp rise in operating cash outflows and a dip in SaaS revenue, offset by strong growth in its North American Direct Sourcing business and a strategic capital raise amid an ongoing takeover.